Benefits of niacin by glycemic status in patients with healed myocardial infarction (from the Coronary Drug Project).

@article{Canner2005BenefitsON,
  title={Benefits of niacin by glycemic status in patients with healed myocardial infarction (from the Coronary Drug Project).},
  author={Paul L. Canner and CurtD. Furberg and Michael L Terrin and Mark E. Mcgovern},
  journal={The American journal of cardiology},
  year={2005},
  volume={95 2},
  pages={
          254-7
        }
}
The Coronary Drug Project, conducted during 1966 to 1974, was a randomized, double-blind, placebo-controlled trial of 5 lipid-modifying agents in 8,341 men with previous myocardial infarction. Among the 5 drug treatment regimens, only niacin significantly reduced the risk of (1) cardiovascular events during a mean follow-up of 6.2 years and (2) total mortality during 6.2 years with study treatment plus an additional 9 years of post-trial follow-up (Figure 1). Cardiovascular and total mortality… CONTINUE READING
BETA

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 67 CITATIONS, ESTIMATED 47% COVERAGE

143 Citations

01020'07'10'13'16'19
Citations per Year
Semantic Scholar estimates that this publication has 143 citations based on the available data.

See our FAQ for additional information.

Similar Papers

Loading similar papers…